Incyte (INCY) Non Operating Income (2017 - 2026)
Incyte (INCY) reported Non Operating Income of $2.8 million for Q1 2026, down 65.74% on a YoY basis from $8.1 million in Q1 2025, and down 51.02% quarter-over-quarter from $5.7 million in Q4 2025.
Incyte (INCY) Non Operating Income (2017 - 2026) Analysis & Trends
Incyte has reported Non Operating Income for 10 years, with the latest figure at $2.8 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 65.74% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $19.8 million (down 13.71% YoY), and the FY2025 full-year result was $25.1 million, up 96.03% from the prior year.
- Non Operating Income for Q1 2026 stood at $2.8 million, down from $5.7 million in the prior quarter.
- The five-year high for Non Operating Income was $46.4 million in Q3 2023, with the low at -$108.0 million in Q4 2023.
- Historically, Non Operating Income has averaged $3.2 million across 5 years, with a median of $4.9 million in 2024.
- The largest YoY upside for Non Operating Income was 8073.95% in 2023 against a maximum downside of 681.66% in 2023.
- Incyte's Non Operating Income stood at -$13.8 million in 2022, then tumbled by 681.66% to -$108.0 million in 2023, then jumped by 101.49% to $1.6 million in 2024, then jumped by 251.15% to $5.7 million in 2025, then slumped by 51.02% to $2.8 million in 2026.
- The last three Non Operating Income figures came in at $2.8 million (Q1 2026), $5.7 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 4.04 Mn |
| Jun 30, 2025 | 7.31 Mn |
| Mar 31, 2025 | 8.10 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | -107.98 Mn |
| Sep 30, 2023 | 46.37 Mn |
| Jun 30, 2023 | 42.67 Mn |
| Mar 31, 2023 | 32.87 Mn |
| Dec 31, 2022 | -13.81 Mn |
| Sep 30, 2022 | 11.51 Mn |
| Jun 30, 2022 | 522,000.00 |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 4.39 Mn |